iRhythm Technologies, Inc. (IRTC) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en San Francisco, CA, United States. El CEO actual es Quentin S. Blackford.
IRTC tiene fecha de IPO 2016-10-20, 2,000 empleados a tiempo completo, cotiza en el NASDAQ Global Select, una capitalización de mercado de $3.98B.
iRhythm Technologies, Inc. is a digital healthcare company headquartered in San Francisco that specializes in ambulatory electrocardiogram (ECG) monitoring solutions for patients at risk of arrhythmias in the United States. The company's flagship Zio service combines wire-free, patch-based wearable biosensors with a cloud-based analytics platform to enable physicians to continuously monitor patients and diagnose cardiac arrhythmias. Its Zio XT and AT monitors are single-use, wearable patches that record patient heartbeats and ECG data for clinical analysis. iRhythm also collaborates with Verily Life Sciences to develop next-generation atrial fibrillation detection and monitoring products, positioning itself at the intersection of wearable technology and cardiac care.
